Partial improvement in negative schizophrenic symptoms after amphetamine
- 1 October 1982
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 78 (2) , 128-130
- https://doi.org/10.1007/bf00432248
Abstract
In stable schizophrenic outpatients with predominantly “defect state” symptomatology amphetamine caused a reduction in negative symptoms that was statistically significant but not complete (i.e. these symptoms remained clinically discernible). The possibility that dopaminergic hypofunction contributes some elements to the schizophrenic defect state is presented, along with some limited data compatible with this concept. These findings are compared to prior studies in recently hospitalized schizophrenic subjects, and discussed with respect to recent theoretical concepts regrding the role of dopamine in schizophrenic psychopathologyThis publication has 13 references indexed in Scilit:
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjectsPsychopharmacology, 1980
- Hyporesponsivity of Chronic Schizophrenic Patients to DextroamphetamineArchives of General Psychiatry, 1976
- Clinical effect of L-dopa on schizophrenia.1976
- Cerebrospinal Fluid Amine Metabolites in Acute SchizophreniaArchives of General Psychiatry, 1975
- The effect of l-dopa on young patients with simple schizophrenia, treated with neuroleptic drugsPsychopharmacology, 1975
- Central Dopamine Turnover in Schizophrenic SyndromesArchives of General Psychiatry, 1974
- Provocation of Schizophrenic Symptoms by Intravenous Administration of MethylphenidateArchives of General Psychiatry, 1973
- Behavioral effects of l-Dopa in schizophrenic patientsPsychopharmacology, 1973
- Effect of L‐Dopa in SchizophreniaPsychiatry and Clinical Neurosciences, 1972